Literature DB >> 2566664

Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis.

R Kuczenski1, D Segal.   

Abstract

The temporal and dose-related behavioral and striatal monoamine response to amphetamine (AMPH) was examined using in vivo microdialysis in freely moving rats. Extracellular dopamine (DA), serotonin (5-HT), and their metabolites were monitored concomitant with detailed characterization of the locomotor and stereotypy profiles. Consistent with previous results, AMPH (0.5-5.0 mg/kg) induced a rapid dose-dependent increase in DA concentration and decrease in the concentrations of the DA metabolites, DOPAC and HVA. DA and its metabolites exhibited contrasting temporal and dose-related patterns, suggesting that the decline in DA metabolites is functionally dissociated from the AMPH-enhanced DA release. In addition, AMPH at doses of 2.0 mg/kg and greater significantly increased extracellular concentrations of 5-HT, which, in contrast to the changes in dopamine, persisted for only 20-40 min. Comparisons of concentrations of DA and 5-HT for individual animals revealed significant correlations both during baseline and drug response, suggesting a possible functional interdependence between dopaminergic and serotonergic activity in striatum. Dose-response comparisons revealed a significant relationship between AMPH-induced increases in behavioral perseveration and the magnitude and duration of the DA release. However, the temporal patterns of the neurotransmitter response and individual components of stereotypy were not parallel, suggesting that the presence of stereotypies is not associated simply with quantitative differences in striatal DA release. By contrast, some features of the behavioral response were significantly correlated with AMPH-induced changes in striatal 5-HT concentrations. Our results suggest that the behavioral response to AMPH may be influenced by the interaction between levels of DA and 5-HT release, as well as by the state of their respective receptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566664      PMCID: PMC6569745     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  73 in total

1.  Synergistically interacting dopamine D1 and NMDA receptors mediate nonvesicular transporter-dependent GABA release from rat striatal medium spiny neurons.

Authors:  A N Schoffelmeer; L J Vanderschuren; T J De Vries; F Hogenboom; G Wardeh; A H Mulder
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

2.  Dopamine and conditioned reinforcement. I. Differential effects of amphetamine microinjections into striatal subregions.

Authors:  A E Kelley; J M Delfs
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans.

Authors:  William W Stoops; J Adam Bennett; Joshua A Lile; Rajkumar J Sevak; Craig R Rush
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-08-28       Impact factor: 5.067

4.  Involvement of dopamine D1 and D2 receptors in the nucleus accumbens core and shell in inhibitory response control.

Authors:  Tommy Pattij; Mieke C W Janssen; Louk J M J Vanderschuren; Anton N M Schoffelmeer; Marcel M van Gaalen
Journal:  Psychopharmacology (Berl)       Date:  2006-09-14       Impact factor: 4.530

5.  Progression of cellular adaptations in medial prefrontal and orbitofrontal cortex in response to repeated amphetamine.

Authors:  Houman Homayoun; Bita Moghaddam
Journal:  J Neurosci       Date:  2006-08-02       Impact factor: 6.167

6.  Effects of selective D1 and D2 dopamine antagonists on the development of behavioral sensitization to apomorphine.

Authors:  B A Mattingly; J K Rowlett; J T Graff; B J Hatton
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 7.  Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine.

Authors:  M F Egan; S Chrapusta; F Karoum; B K Lipska; R J Wyatt
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

8.  Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats.

Authors:  P E Paulson; T E Robinson
Journal:  Synapse       Date:  1995-01       Impact factor: 2.562

9.  Unilateral neonatal intracerebroventricular 6-hydroxydopamine administration in rats: I. Effects on spontaneous and drug-induced rotational behaviour and on postmortem monoamine levels.

Authors:  J Luthman; M Herrera-Marschitz; E Lindqvist
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

10.  Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine.

Authors:  Ronald Kuczenski; David S Segal
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.